Antabio to participate in Nature’s Webcast on Combating Antibiotic Resistance on March 9

Antabio signs the Industry call for new antimicrobial business models presented at the World Economic Forum, Davos

ANTABIO receives €4 Million to develop new drugs to treat chronic infections in Cystic Fibrosis patients

Antabio is now a member of the newly launched BEAM Alliance

Antabio awarded EUR 1 million funding from Bpifrance to support the discovery of New Gram-Negative Anti-Infective Agents

Antabio receives the Tremplin Entreprises 2015 Award

Antabio receives funding from the Midi-Pyrénées Region to support the expansion of its R&D capabilities

Antabio awardee of the “Concours Mondial de l’Innovation 2030” Worldwide Innovation Challenge

Antabio profiled in the June 2014 issue of Nature Biopharma Dealmakers on infectious diseases

Argenta and Antabio Announce Achievement of Milestone in their Anti-bacterial Drug Discovery Collaboration